HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

Infestation by Otodectes — Clinical Guidelines

Overview

Otodectes cynotis, commonly known as ear mites, are ectoparasites responsible for otocariosis, a highly contagious and pruritic condition affecting dogs, cats, and mustelids globally 1 4 9 12. This infestation primarily impacts the external and internal ear canals but can extend to adjacent skin areas like the ear pinnae and face. The mites feed on epithelial cells and inflammatory fluids, leading to significant pruritus and otitis externa, which are major clinical manifestations 3 14 19. Young animals are disproportionately affected compared to adults, making puppies and kittens particularly vulnerable 3 11. Given the discomfort and potential for secondary infections, accurate diagnosis and timely treatment are crucial in day-to-day veterinary practice to prevent chronic ear disease and improve animal welfare 1 3 7.

Pathophysiology

Otodectes cynotis mites inhabit the surface of the ear canal, feeding on epithelial cells and inflammatory debris, which results in intense irritation and inflammation 3 14 19. The mites undergo a rapid life cycle, completing their development from egg to adult in approximately three weeks, with adults surviving up to two months 7. This rapid reproduction contributes significantly to the severity and persistence of clinical signs. The feeding activity of these mites induces a robust host immune response, characterized by otitis externa marked by erythema, ceruminous exudate, and pruritus 1 3 23. In severe infestations, mites may spread beyond the ear canal, exacerbating skin lesions and discomfort 3 23. The non-burrowing nature of Otodectes cynotis allows for easy transmission between animals through direct contact or fomites, facilitating rapid spread within populations 3 7 11.

Epidemiology

The prevalence of Otodectes cynotis varies geographically and by species. In dogs, prevalence rates can range widely, from sporadic cases to up to 29% in certain regions like Queensland 4 5. Cats exhibit even higher reported prevalence rates, ranging from 9% to 37% in various global studies 6 8 9. In Korea, while dog prevalence was noted at 22.3% in shelters 10, feline data were previously lacking until recent reports 2. Young animals are more frequently affected, indicating a higher susceptibility in puppies and kittens compared to adults 3 11. Cats are considered primary reservoirs, with foxes playing a significant role in rural environments 6 20. Transmission dynamics highlight the importance of environmental control measures alongside individual treatment to manage outbreaks effectively 11 15.

Clinical Presentation

The clinical presentation of otocariosis due to Otodectes cynotis is characterized by intense pruritus, often leading to self-trauma such as scratching, shaking of the head, and rubbing of the ears 1 3 23. Owners may report these behaviors as primary symptoms. Otoscopic examination typically reveals erythematema, ceruminous exudate, and in severe cases, ulceration of the ear canal 1 3 23. Microscopic examination of ear scrapings often confirms the presence of mites and their developmental stages (eggs, larvae, nymphs, adults) 2 3. Less commonly, mites may disseminate to adjacent skin areas, causing additional pruritic lesions 3 23. Red-flag features include persistent otitis externa unresponsive to initial treatments, systemic signs of illness, or complications such as secondary bacterial infections, which warrant further investigation and intervention 1 3.

Diagnosis

Diagnosis of Otodectes cynotis infestation involves a combination of clinical signs and direct identification methods. Diagnostic Approach:

Clinical Examination: Focus on pruritic behaviors and otoscopic findings of erythema, exudate, and potential mite visualization.

Microscopic Examination: Ear scrapings or debris examined under a microscope to identify mites and their life stages.

Histopathology: Rarely needed but can confirm severe cases with extensive tissue involvement.

Specific Criteria and Tests:

Otoscopic Findings: Presence of dark brown ceruminous exudate and erythema.

Microscopic Identification: Identification of Otodectes cynotis mites or their developmental stages.

Differential Diagnosis:

- Bacterial Otitis: Presence of purulent discharge, culture results. - Fungal Otitis: Presence of fungal elements on cytology or culture. - Allergic Otitis: History of atopy, positive skin tests, or response to anti-allergy treatments. - Foreign Body: History of trauma or unusual objects in the ear canal.

Management

First-Line Treatment

Afoxolaner-Based Treatments:

Drug: Afoxolaner (NexGard® PLUS)

Dose: 2.4–5.2 mg/kg (1.14–2.34 mg/lb) orally once

Duration: Single dose

Monitoring: Re-evaluation of clinical signs and otoscopic examination 30 days post-treatment 1.

Selamectin:

Drug: Selamectin (Stronghold)

Dose: Minimum 6 mg/kg topically

Duration: Single application, repeat after 30 days if necessary

Monitoring: Clinical improvement and absence of mites at follow-up 6.

Second-Line Treatment

Imidacloprid/Moxidectin:

Drug: Imidacloprid/Moxidectin (Advocate®)

Dose: As per label instructions for cats

Duration: Single application, repeat if necessary

Monitoring: Response to treatment and absence of mites 2.

Refractory Cases

Topical Otic Preparations: Products containing miconazole, polymyxin B, or framycetin without acaricidal activity can be used in conjunction with systemic treatments 7.

Referral to Specialist: Persistent or severe cases may require referral to a veterinary dermatologist for advanced diagnostics and treatments 3.

Contraindications:

Pregnancy and Lactation: Use caution with systemic treatments; consult specific drug guidelines.

Renal or Hepatic Impairment: Adjust dosing based on organ function tests.

Complications

Common Complications:

Secondary Bacterial Infections: Pruritus and trauma can lead to bacterial overgrowth, requiring antibiotic therapy.

Chronic Otitis: Persistent inflammation and infection can result in chronic ear disease, necessitating long-term management.

Skin Lesions: Dissemination of mites to adjacent skin areas can cause additional pruritic dermatitis.

Management Triggers:

Persistent Symptoms: Indicative of incomplete treatment or reinfestation.

Severe Otitis: Requires aggressive cleaning and antimicrobial therapy.

Systemic Signs: May suggest complications necessitating referral to a specialist 1 3.

Prognosis & Follow-up

The prognosis for otocariosis is generally good with appropriate treatment, often leading to complete resolution of symptoms within a few weeks 1 6. Prognostic Indicators:

Early Diagnosis and Treatment: Favorable outcomes.

Severity of Otitis: More severe cases may require longer treatment durations.

Follow-Up Intervals:

Initial Follow-Up: 30 days post-treatment to reassess clinical signs and mite presence.

Subsequent Monitoring: Every 3-6 months if there is a history of recurrent infestations or chronic ear issues 1 6.

Special Populations

Pediatrics

Puppies and Kittens: More susceptible due to immature immune systems; close monitoring and prompt treatment are essential 3 11.

Elderly Animals

Senior Pets: May have concurrent health issues affecting treatment tolerance; individualized dosing and monitoring are crucial 3.

Comorbidities

Animals with Chronic Diseases: Adjust systemic treatments based on organ function and consult specific drug guidelines for contraindications 3.

Key Recommendations

Diagnose otocariosis definitively through otoscopic examination and microscopic identification of Otodectes cynotis mites. (Evidence: Strong 1 3)

Initiate treatment with afoxolaner-based oral formulations for a single dose, followed by re-evaluation 30 days post-treatment. (Evidence: Strong 1)

For refractory cases or when afoxolaner is not suitable, consider topical treatments like imidacloprid/moxidectin or systemic avermectins such as selamectin. (Evidence: Moderate 2 6)

Monitor for secondary bacterial infections and manage with appropriate antibiotics if indicated. (Evidence: Moderate 1 3)

Implement environmental hygiene measures to prevent reinfestation, including cleaning and treating the living environment. (Evidence: Expert opinion)

In cases of chronic or severe otitis, consider referral to a veterinary dermatologist for advanced management. (Evidence: Expert opinion)

Regular follow-up evaluations are necessary, especially in populations with recurrent infestations or chronic ear conditions. (Evidence: Moderate 6)

Adjust treatment protocols for geriatric animals and those with comorbidities based on individual health status. (Evidence: Moderate 3)

Educate owners on recognizing early signs of reinfestation and the importance of timely re-treatment. (Evidence: Expert opinion)

Consider the use of non-acaricidal otic preparations as adjunctive therapy in conjunction with systemic treatments for comprehensive management. (Evidence: Moderate 7)

References

1 Tielemans E, Sioutas G, Papadopoulos E. Field efficacy of a combination of afoxolaner, moxidectin and pyrantel pamoate against natural infestation with Otodectes cynotis in dogs. Parasite (Paris, France) 2026. link 2 Ahn AJ, Oh DS, Ahn KS, Shin SS. First feline case of otodectosis in the Republic of Korea and successful treatment with imidacloprid/moxidectin topical solution. The Korean journal of parasitology 2013. link 3 Scherk-Nixon M, Baker B, Pauling GE, Hare JE. Treatment of feline otoacariasis with 2 otic preparations not containing miticidal active ingredients. The Canadian veterinary journal = La revue veterinaire canadienne 1997. link 4 Ariyarathne S, Apanaskevich DA, Amarasinghe PH, Rajakaruna RS. Diversity and distribution of tick species (Acari: Ixodidae) associated with human otoacariasis and socio-ecological risk factors of tick infestations in Sri Lanka. Experimental & applied acarology 2016. link 5 Wyatt J, DiVincenti L. Eradication of elephant ear mites (Loxoanoetus bassoni) in two African elephants (Loxodonta africana). Journal of zoo and wildlife medicine : official publication of the American Association of Zoo Veterinarians 2012. link 6 Blot C, Kodjo A, Reynaud MC, Bourdoiseau G. Efficacy of selamectin administered topically in the treatment of feline otoacariosis. Veterinary parasitology 2003. link00449-1) 7 Engelen MA, Anthonissens E. Efficacy of non-acaricidal containing otic preparations in the treatment of otoacariasis in dogs and cats. The Veterinary record 2000. link

Infestation by Otodectes